BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2 AND Treatment
6 results:

  • 1. Benign and Malignant tumors of the Pineal Region.
    Upadhyayula PS; Neira JA; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():153-173. PubMed ID: 37452938
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pineal Gland tumor Microenvironment.
    Choque-Velasquez J; Baluszek S; Colasanti R; Muhammad S; Hernesniemi J
    Adv Exp Med Biol; 2020; 1296():137-150. PubMed ID: 34185290
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain tumor Consortium registry study.
    Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
    Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
    Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
    Acta Neuropathol; 2020 Feb; 139(2):259-271. PubMed ID: 31802236
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.
    Yin J; Park G; Lee JE; Choi EY; Park JY; Kim TH; Park N; Jin X; Jung JE; Shin D; Hong JH; Kim H; Yoo H; Lee SH; Kim YJ; Park JB; Kim JH
    Brain; 2015 Sep; 138(Pt 9):2553-70. PubMed ID: 26121981
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.
    Puppin C; Durante C; Sponziello M; Verrienti A; Pecce V; Lavarone E; Baldan F; Campese AF; Boichard A; Lacroix L; Russo D; Filetti S; Damante G
    Endocrine; 2014 Nov; 47(2):528-36. PubMed ID: 24569963
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.